An initial study on the predictive value using multiple MRI characteristics for Ki-67 labeling index in glioma
Ki-67 labeling index (LI) is an important indicator of tumor cell proliferation in glioma, which can only be obtained by postoperative biopsy at present. This study aimed to explore the correlation between Ki-67 LI and apparent diffusion coefficient (ADC) parameters and to predict the level of Ki-67...
Saved in:
| Published in | Journal of translational medicine Vol. 21; no. 1; pp. 119 - 11 |
|---|---|
| Main Authors | , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
11.02.2023
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Ki-67 labeling index (LI) is an important indicator of tumor cell proliferation in glioma, which can only be obtained by postoperative biopsy at present. This study aimed to explore the correlation between Ki-67 LI and apparent diffusion coefficient (ADC) parameters and to predict the level of Ki-67 LI noninvasively before surgery by multiple MRI characteristics.
Preoperative MRI data of 166 patients with pathologically confirmed glioma in our hospital from 2016 to 2020 were retrospectively analyzed. The cut-off point of Ki-67 LI for glioma grading was defined. The differences in MRI characteristics were compared between the low and high Ki-67 LI groups. The receiver operating characteristic (ROC) curve was used to estimate the accuracy of each ADC parameter in predicting the Ki-67 level, and finally a multivariate logistic regression model was constructed based on the results of ROC analysis.
ADC
, ADC
, rADC
, rADC
and Ki-67 LI showed a negative correlation (r = - 0.478, r = - 0.369, r = - 0.488, r = - 0.388, all P < 0.001). The Ki-67 LI of low-grade gliomas (LGGs) was different from that of high-grade gliomas (HGGs), and the cut-off point of Ki-67 LI for distinguishing LGGs from HGGs was 9.5%, with an area under the ROC curve (AUROC) of 0.962 (95%CI 0.933-0.990). The ADC parameters in the high Ki-67 group were significantly lower than those in the low Ki-67 group (all P < 0.05). The peritumoral edema (PTE) of gliomas in the high Ki-67 LI group was higher than that in the low Ki-67 LI group (P < 0.05). The AUROC of Ki-67 LI level assessed by the multivariate logistic regression model was 0.800 (95%CI 0.721-0.879).
There was a negative correlation between ADC parameters and Ki-67 LI, and the multivariate logistic regression model combined with peritumoral edema and ADC parameters could improve the prediction ability of Ki-67 LI. |
|---|---|
| AbstractList | Ki-67 labeling index (LI) is an important indicator of tumor cell proliferation in glioma, which can only be obtained by postoperative biopsy at present. This study aimed to explore the correlation between Ki-67 LI and apparent diffusion coefficient (ADC) parameters and to predict the level of Ki-67 LI noninvasively before surgery by multiple MRI characteristics.
Preoperative MRI data of 166 patients with pathologically confirmed glioma in our hospital from 2016 to 2020 were retrospectively analyzed. The cut-off point of Ki-67 LI for glioma grading was defined. The differences in MRI characteristics were compared between the low and high Ki-67 LI groups. The receiver operating characteristic (ROC) curve was used to estimate the accuracy of each ADC parameter in predicting the Ki-67 level, and finally a multivariate logistic regression model was constructed based on the results of ROC analysis.
ADC
, ADC
, rADC
, rADC
and Ki-67 LI showed a negative correlation (r = - 0.478, r = - 0.369, r = - 0.488, r = - 0.388, all P < 0.001). The Ki-67 LI of low-grade gliomas (LGGs) was different from that of high-grade gliomas (HGGs), and the cut-off point of Ki-67 LI for distinguishing LGGs from HGGs was 9.5%, with an area under the ROC curve (AUROC) of 0.962 (95%CI 0.933-0.990). The ADC parameters in the high Ki-67 group were significantly lower than those in the low Ki-67 group (all P < 0.05). The peritumoral edema (PTE) of gliomas in the high Ki-67 LI group was higher than that in the low Ki-67 LI group (P < 0.05). The AUROC of Ki-67 LI level assessed by the multivariate logistic regression model was 0.800 (95%CI 0.721-0.879).
There was a negative correlation between ADC parameters and Ki-67 LI, and the multivariate logistic regression model combined with peritumoral edema and ADC parameters could improve the prediction ability of Ki-67 LI. Abstract Background and purpose Ki-67 labeling index (LI) is an important indicator of tumor cell proliferation in glioma, which can only be obtained by postoperative biopsy at present. This study aimed to explore the correlation between Ki-67 LI and apparent diffusion coefficient (ADC) parameters and to predict the level of Ki-67 LI noninvasively before surgery by multiple MRI characteristics. Methods Preoperative MRI data of 166 patients with pathologically confirmed glioma in our hospital from 2016 to 2020 were retrospectively analyzed. The cut-off point of Ki-67 LI for glioma grading was defined. The differences in MRI characteristics were compared between the low and high Ki-67 LI groups. The receiver operating characteristic (ROC) curve was used to estimate the accuracy of each ADC parameter in predicting the Ki-67 level, and finally a multivariate logistic regression model was constructed based on the results of ROC analysis. Results ADCmin, ADCmean, rADCmin, rADCmean and Ki-67 LI showed a negative correlation (r = − 0.478, r = − 0.369, r = − 0.488, r = − 0.388, all P < 0.001). The Ki-67 LI of low-grade gliomas (LGGs) was different from that of high-grade gliomas (HGGs), and the cut-off point of Ki-67 LI for distinguishing LGGs from HGGs was 9.5%, with an area under the ROC curve (AUROC) of 0.962 (95%CI 0.933–0.990). The ADC parameters in the high Ki-67 group were significantly lower than those in the low Ki-67 group (all P < 0.05). The peritumoral edema (PTE) of gliomas in the high Ki-67 LI group was higher than that in the low Ki-67 LI group (P < 0.05). The AUROC of Ki-67 LI level assessed by the multivariate logistic regression model was 0.800 (95%CI 0.721–0.879). Conclusions There was a negative correlation between ADC parameters and Ki-67 LI, and the multivariate logistic regression model combined with peritumoral edema and ADC parameters could improve the prediction ability of Ki-67 LI. Ki-67 labeling index (LI) is an important indicator of tumor cell proliferation in glioma, which can only be obtained by postoperative biopsy at present. This study aimed to explore the correlation between Ki-67 LI and apparent diffusion coefficient (ADC) parameters and to predict the level of Ki-67 LI noninvasively before surgery by multiple MRI characteristics.BACKGROUND AND PURPOSEKi-67 labeling index (LI) is an important indicator of tumor cell proliferation in glioma, which can only be obtained by postoperative biopsy at present. This study aimed to explore the correlation between Ki-67 LI and apparent diffusion coefficient (ADC) parameters and to predict the level of Ki-67 LI noninvasively before surgery by multiple MRI characteristics.Preoperative MRI data of 166 patients with pathologically confirmed glioma in our hospital from 2016 to 2020 were retrospectively analyzed. The cut-off point of Ki-67 LI for glioma grading was defined. The differences in MRI characteristics were compared between the low and high Ki-67 LI groups. The receiver operating characteristic (ROC) curve was used to estimate the accuracy of each ADC parameter in predicting the Ki-67 level, and finally a multivariate logistic regression model was constructed based on the results of ROC analysis.METHODSPreoperative MRI data of 166 patients with pathologically confirmed glioma in our hospital from 2016 to 2020 were retrospectively analyzed. The cut-off point of Ki-67 LI for glioma grading was defined. The differences in MRI characteristics were compared between the low and high Ki-67 LI groups. The receiver operating characteristic (ROC) curve was used to estimate the accuracy of each ADC parameter in predicting the Ki-67 level, and finally a multivariate logistic regression model was constructed based on the results of ROC analysis.ADCmin, ADCmean, rADCmin, rADCmean and Ki-67 LI showed a negative correlation (r = - 0.478, r = - 0.369, r = - 0.488, r = - 0.388, all P < 0.001). The Ki-67 LI of low-grade gliomas (LGGs) was different from that of high-grade gliomas (HGGs), and the cut-off point of Ki-67 LI for distinguishing LGGs from HGGs was 9.5%, with an area under the ROC curve (AUROC) of 0.962 (95%CI 0.933-0.990). The ADC parameters in the high Ki-67 group were significantly lower than those in the low Ki-67 group (all P < 0.05). The peritumoral edema (PTE) of gliomas in the high Ki-67 LI group was higher than that in the low Ki-67 LI group (P < 0.05). The AUROC of Ki-67 LI level assessed by the multivariate logistic regression model was 0.800 (95%CI 0.721-0.879).RESULTSADCmin, ADCmean, rADCmin, rADCmean and Ki-67 LI showed a negative correlation (r = - 0.478, r = - 0.369, r = - 0.488, r = - 0.388, all P < 0.001). The Ki-67 LI of low-grade gliomas (LGGs) was different from that of high-grade gliomas (HGGs), and the cut-off point of Ki-67 LI for distinguishing LGGs from HGGs was 9.5%, with an area under the ROC curve (AUROC) of 0.962 (95%CI 0.933-0.990). The ADC parameters in the high Ki-67 group were significantly lower than those in the low Ki-67 group (all P < 0.05). The peritumoral edema (PTE) of gliomas in the high Ki-67 LI group was higher than that in the low Ki-67 LI group (P < 0.05). The AUROC of Ki-67 LI level assessed by the multivariate logistic regression model was 0.800 (95%CI 0.721-0.879).There was a negative correlation between ADC parameters and Ki-67 LI, and the multivariate logistic regression model combined with peritumoral edema and ADC parameters could improve the prediction ability of Ki-67 LI.CONCLUSIONSThere was a negative correlation between ADC parameters and Ki-67 LI, and the multivariate logistic regression model combined with peritumoral edema and ADC parameters could improve the prediction ability of Ki-67 LI. Background and purposeKi-67 labeling index (LI) is an important indicator of tumor cell proliferation in glioma, which can only be obtained by postoperative biopsy at present. This study aimed to explore the correlation between Ki-67 LI and apparent diffusion coefficient (ADC) parameters and to predict the level of Ki-67 LI noninvasively before surgery by multiple MRI characteristics.MethodsPreoperative MRI data of 166 patients with pathologically confirmed glioma in our hospital from 2016 to 2020 were retrospectively analyzed. The cut-off point of Ki-67 LI for glioma grading was defined. The differences in MRI characteristics were compared between the low and high Ki-67 LI groups. The receiver operating characteristic (ROC) curve was used to estimate the accuracy of each ADC parameter in predicting the Ki-67 level, and finally a multivariate logistic regression model was constructed based on the results of ROC analysis.ResultsADCmin, ADCmean, rADCmin, rADCmean and Ki-67 LI showed a negative correlation (r = − 0.478, r = − 0.369,r = − 0.488, r = − 0.388, all P < 0.001). The Ki-67 LI of low-grade gliomas (LGGs) was different from that of high-grade gliomas (HGGs), and the cut-off point of Ki-67 LI for distinguishing LGGs from HGGs was 9.5%, with an area under the ROC curve (AUROC) of 0.962 (95%CI 0.933–0.990). The ADC parameters in the high Ki-67 group were significantly lower than those in the low Ki-67 group (all P < 0.05). The peritumoral edema (PTE) of gliomas in the high Ki-67 LI group was higher than that in the low Ki-67 LI group (P < 0.05). The AUROC of Ki-67 LI level assessed by the multivariate logistic regression model was 0.800 (95%CI 0.721–0.879).ConclusionsThere was a negative correlation between ADC parameters and Ki-67 LI, and the multivariate logistic regression model combined with peritumoral edema and ADC parameters could improve the prediction ability of Ki-67 LI. Ki-67 labeling index (LI) is an important indicator of tumor cell proliferation in glioma, which can only be obtained by postoperative biopsy at present. This study aimed to explore the correlation between Ki-67 LI and apparent diffusion coefficient (ADC) parameters and to predict the level of Ki-67 LI noninvasively before surgery by multiple MRI characteristics. Preoperative MRI data of 166 patients with pathologically confirmed glioma in our hospital from 2016 to 2020 were retrospectively analyzed. The cut-off point of Ki-67 LI for glioma grading was defined. The differences in MRI characteristics were compared between the low and high Ki-67 LI groups. The receiver operating characteristic (ROC) curve was used to estimate the accuracy of each ADC parameter in predicting the Ki-67 level, and finally a multivariate logistic regression model was constructed based on the results of ROC analysis. ADC.sub.min, ADC.sub.mean, rADC.sub.min, rADC.sub.mean and Ki-67 LI showed a negative correlation (r = - 0.478, r = - 0.369, r = - 0.488, r = - 0.388, all P < 0.001). The Ki-67 LI of low-grade gliomas (LGGs) was different from that of high-grade gliomas (HGGs), and the cut-off point of Ki-67 LI for distinguishing LGGs from HGGs was 9.5%, with an area under the ROC curve (AUROC) of 0.962 (95%CI 0.933-0.990). The ADC parameters in the high Ki-67 group were significantly lower than those in the low Ki-67 group (all P < 0.05). The peritumoral edema (PTE) of gliomas in the high Ki-67 LI group was higher than that in the low Ki-67 LI group (P < 0.05). The AUROC of Ki-67 LI level assessed by the multivariate logistic regression model was 0.800 (95%CI 0.721-0.879). There was a negative correlation between ADC parameters and Ki-67 LI, and the multivariate logistic regression model combined with peritumoral edema and ADC parameters could improve the prediction ability of Ki-67 LI. Background and purpose Ki-67 labeling index (LI) is an important indicator of tumor cell proliferation in glioma, which can only be obtained by postoperative biopsy at present. This study aimed to explore the correlation between Ki-67 LI and apparent diffusion coefficient (ADC) parameters and to predict the level of Ki-67 LI noninvasively before surgery by multiple MRI characteristics. Methods Preoperative MRI data of 166 patients with pathologically confirmed glioma in our hospital from 2016 to 2020 were retrospectively analyzed. The cut-off point of Ki-67 LI for glioma grading was defined. The differences in MRI characteristics were compared between the low and high Ki-67 LI groups. The receiver operating characteristic (ROC) curve was used to estimate the accuracy of each ADC parameter in predicting the Ki-67 level, and finally a multivariate logistic regression model was constructed based on the results of ROC analysis. Results ADC.sub.min, ADC.sub.mean, rADC.sub.min, rADC.sub.mean and Ki-67 LI showed a negative correlation (r = - 0.478, r = - 0.369, r = - 0.488, r = - 0.388, all P < 0.001). The Ki-67 LI of low-grade gliomas (LGGs) was different from that of high-grade gliomas (HGGs), and the cut-off point of Ki-67 LI for distinguishing LGGs from HGGs was 9.5%, with an area under the ROC curve (AUROC) of 0.962 (95%CI 0.933-0.990). The ADC parameters in the high Ki-67 group were significantly lower than those in the low Ki-67 group (all P < 0.05). The peritumoral edema (PTE) of gliomas in the high Ki-67 LI group was higher than that in the low Ki-67 LI group (P < 0.05). The AUROC of Ki-67 LI level assessed by the multivariate logistic regression model was 0.800 (95%CI 0.721-0.879). Conclusions There was a negative correlation between ADC parameters and Ki-67 LI, and the multivariate logistic regression model combined with peritumoral edema and ADC parameters could improve the prediction ability of Ki-67 LI. Keywords: Glioma, Magnetic resonance imaging, Ki-67 labeling index, Diffusion-weighted magnetic resonance imaging, Apparent diffusion coefficient, Peritumoral edema |
| ArticleNumber | 119 |
| Audience | Academic |
| Author | Du, Ningfang Tang, Feng Li, Shihong Mao, Renling Shu, Weiquan Li, Kefeng Xu, Xinxin Ye, Yao Lin, Guangwu Fang, Xuhao Deng, Yao |
| Author_xml | – sequence: 1 givenname: Ningfang surname: Du fullname: Du, Ningfang – sequence: 2 givenname: Weiquan surname: Shu fullname: Shu, Weiquan – sequence: 3 givenname: Kefeng surname: Li fullname: Li, Kefeng – sequence: 4 givenname: Yao surname: Deng fullname: Deng, Yao – sequence: 5 givenname: Xinxin surname: Xu fullname: Xu, Xinxin – sequence: 6 givenname: Yao surname: Ye fullname: Ye, Yao – sequence: 7 givenname: Feng surname: Tang fullname: Tang, Feng – sequence: 8 givenname: Renling surname: Mao fullname: Mao, Renling – sequence: 9 givenname: Guangwu surname: Lin fullname: Lin, Guangwu – sequence: 10 givenname: Shihong orcidid: 0000-0002-2204-7593 surname: Li fullname: Li, Shihong – sequence: 11 givenname: Xuhao surname: Fang fullname: Fang, Xuhao |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36774480$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9Ul1rFDEUHaRiP_QP-CABX3yZmq9JMi9CKX4sVgTR55DJ3NnNkk3WZGZr_72ZbqvdIhJIws05594Tzml1FGKAqnpJ8DkhSrzNhLZC1piyGrO2wfX1k-qEcNnWjZLi6MH9uDrNeY0x5Q1vn1XHTEjJucInVbgIyAU3OuNRHqf-BsWAxhWgbYLe2dHtAO2MnwBN2YUl2kx-dFsP6Mu3BbIrk4wdIbk8OpvREBP67GohkTcd-BnvQg-_yo6W3sWNeV49HYzP8OLuPKt-fHj__fJTffX14-Ly4qq2jWBjzQzpuBj6ngxCNgRLasUg25aD6pgYhALGDAycwWA7orgSlClpWUNbqpQV7Kxa7HX7aNZ6m9zGpBsdjdO3hZiW2qQyswfNhQSqpGwkVrzpcQdEEdIp0XeqoxYXrXd7re3UbaC3EMZk_IHo4UtwK72MO922lHLBi8CbO4EUf06QR71x2YL3JkCcsqaluSCsJTP09SPoOk4plK-aUVIqiTn7i1qaYsCFIZa-dhbVF5LNP0bpPPf5P1Bl9bBxtkRpcKV-QHj10Ogfh_dpKQC1B9gUc04waOtGM7o4-3ZeE6znYOp9MHUJpr4Npr4uVPqIeq_-H9JviDfjvA |
| CitedBy_id | crossref_primary_10_1097_MD_0000000000033955 crossref_primary_10_12677_ACM_2023_13112419 crossref_primary_10_1016_j_talanta_2024_126538 crossref_primary_10_1097_RCT_0000000000001737 crossref_primary_10_3389_fendo_2024_1383814 crossref_primary_10_1016_j_acra_2023_09_010 crossref_primary_10_3390_biomedicines11071968 crossref_primary_10_1177_17562864241237851 crossref_primary_10_1186_s12880_025_01555_x |
| Cites_doi | 10.1007/s10014-021-00417-y 10.1093/neuonc/noz004 10.1093/neuonc/noab106 10.1016/j.crad.2015.06.082 10.1111/jon.12789 10.1148/radiol.2020191832 10.1093/neuonc/now256 10.1007/s11060-015-1909-8 10.1038/s41598-021-95958-9 10.1016/j.mri.2021.11.001 10.3389/fonc.2022.873839 10.1002/1097-0142(19940915)74:6<1784::AID-CNCR2820740622>3.0.CO;2-D 10.1007/s10014-012-0084-2 10.1111/j.1349-7006.2009.01259.x 10.4103/0973-1482.139154 10.1007/BF02893360 10.1148/radiology.161.2.3763909 10.1016/j.wneu.2018.08.163 10.1093/neuonc/nos128 10.1148/radiology.170.1.2535765 10.1259/bjr.20170930 10.31557/APJCP.2020.21.4.1063 10.1186/s12943-022-01513-z 10.1007/s00412-018-0659-8 10.1056/NEJMoa043330 10.1177/0300060520914466 10.1016/j.canlet.2020.02.002 10.1148/radiol.2413051276 10.3389/fnins.2021.783361 10.1007/s00330-004-2381-6 10.1016/j.canlet.2020.10.050 10.1007/s00401-016-1545-1 10.1093/neuonc/nox183 10.1111/j.1440-1789.2006.00724.x 10.3389/fneur.2020.592155 10.1016/j.clineuro.2016.10.018 10.1093/neuonc/noq009 10.1158/0008-5472.CAN-13-3534 10.1007/s00330-019-06548-3 10.1016/j.ccell.2020.04.001 10.1007/s00401-010-0725-7 10.1007/s00330-021-07959-x 10.1148/radiol.11110686 10.1016/j.neo.2014.06.003 10.1136/jclinpath-2015-203340 10.1002/jmri.25986 10.1111/ajco.12826 10.1007/s00234-015-1606-5 10.1007/s00330-021-08522-4 10.1002/jmri.25963 10.1016/j.seizure.2013.08.004 10.1093/neuonc/nou087 10.1016/j.ejrad.2018.11.003 10.1016/j.wneu.2019.02.006 10.1158/2159-8290.CD-20-1474 |
| ContentType | Journal Article |
| Copyright | 2023. The Author(s). COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2023 |
| Copyright_xml | – notice: 2023. The Author(s). – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2023 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12967-023-03950-w |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1479-5876 |
| EndPage | 11 |
| ExternalDocumentID | oai_doaj_org_article_467e2877570845d0be1811b86db8b2c0 PMC9922464 A736751220 36774480 10_1186_s12967_023_03950_w |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Taiwan Germany |
| GeographicLocations_xml | – name: Taiwan – name: Germany |
| GrantInformation_xml | – fundername: ; grantid: SHDC2022CRT025 – fundername: ; grantid: SKLY2022CRT402 |
| GroupedDBID | --- 0R~ 29L 2WC 53G 5VS 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ TR2 TUS UKHRP WOQ WOW XSB ~8M -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM PMFND 7T5 7XB 8FK AZQEC DWQXO H94 K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c563t-3a1b46fdd1f6751072c6f7994e8b36f68e33aef43efcb184862387c3529288c63 |
| IEDL.DBID | M48 |
| ISSN | 1479-5876 |
| IngestDate | Wed Aug 27 01:24:48 EDT 2025 Thu Aug 21 18:38:25 EDT 2025 Fri Jul 11 01:25:21 EDT 2025 Fri Jul 25 22:46:11 EDT 2025 Tue Jun 17 21:32:02 EDT 2025 Tue Jun 10 20:42:49 EDT 2025 Thu Jan 02 22:53:56 EST 2025 Thu Apr 24 22:57:24 EDT 2025 Tue Jul 01 02:59:39 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Ki-67 labeling index Glioma Magnetic resonance imaging Peritumoral edema Diffusion-weighted magnetic resonance imaging Apparent diffusion coefficient |
| Language | English |
| License | 2023. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c563t-3a1b46fdd1f6751072c6f7994e8b36f68e33aef43efcb184862387c3529288c63 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-2204-7593 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12967-023-03950-w |
| PMID | 36774480 |
| PQID | 2777787043 |
| PQPubID | 43076 |
| PageCount | 11 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_467e2877570845d0be1811b86db8b2c0 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9922464 proquest_miscellaneous_2775613914 proquest_journals_2777787043 gale_infotracmisc_A736751220 gale_infotracacademiconefile_A736751220 pubmed_primary_36774480 crossref_citationtrail_10_1186_s12967_023_03950_w crossref_primary_10_1186_s12967_023_03950_w |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-02-11 |
| PublicationDateYYYYMMDD | 2023-02-11 |
| PublicationDate_xml | – month: 02 year: 2023 text: 2023-02-11 day: 11 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | Journal of translational medicine |
| PublicationTitleAlternate | J Transl Med |
| PublicationYear | 2023 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | F Li (3950_CR58) 2016; 151 T Engelhorn (3950_CR53) 2009; 100 N Chaudhary (3950_CR14) 2021; 13 Q Zeng (3950_CR17) 2018; 48 P Seow (3950_CR33) 2018; 91 RF Barajas Jr (3950_CR27) 2012; 14 R Yan (3950_CR41) 2016; 58 PC Johnson (3950_CR25) 1989; 170 SJ Price (3950_CR26) 2004; 14 NS White (3950_CR18) 2014; 74 X Sun (3950_CR28) 2020; 48 N Du (3950_CR52) 2022; 12 MS Berger (3950_CR23) 1994; 74 J Maynard (3950_CR30) 2020; 296 C Henker (3950_CR34) 2019; 125 DN Louis (3950_CR2) 2016; 131 Y Cui (3950_CR55) 2020; 11 AJ Skjulsvik (3950_CR47) 2014; 7 J Qiu (3950_CR29) 2022; 86 T Jiang (3950_CR1) 2021; 499 MJ Van Den Bent (3950_CR9) 2010; 120 EDH Gates (3950_CR11) 2019; 21 M Thotakura (3950_CR13) 2014; 10 JG Nicholson (3950_CR7) 2021; 11 KY Lim (3950_CR36) 2022; 39 X Sun (3950_CR45) 2018; 127 R Stupp (3950_CR4) 2005; 352 DN Louis (3950_CR5) 2021; 23 Y Xie (3950_CR19) 2021; 15 K Yang (3950_CR21) 2022; 21 K Yang (3950_CR22) 2018; 120 S Li (3950_CR46) 2021; 31 S Higano (3950_CR40) 2006; 241 A Fathi Kazerooni (3950_CR24) 2018; 48 DP Cahill (3950_CR8) 2015; 125 RH Dahlrot (3950_CR12) 2021; 11 Y Kang (3950_CR42) 2011; 261 TS Armstrong (3950_CR35) 2010; 12 J Zhang (3950_CR10) 2018; 109 AL Johannessen (3950_CR32) 2006; 12 MH Faria (3950_CR50) 2006; 26 X Wang (3950_CR54) 2015; 30 QT Ostrom (3950_CR3) 2014; 16 M Kim (3950_CR16) 2020; 30 Y Sun (3950_CR48) 2022; 32 H Zhou (3950_CR51) 2017; 19 D Le Bihan (3950_CR57) 1986; 161 Y Yuan (3950_CR37) 2013; 22 E Wong (3950_CR39) 2019; 15 S Richards-Taylor (3950_CR15) 2016; 69 ML Suvà (3950_CR43) 2020; 37 Y Okita (3950_CR38) 2012; 29 GJ Baker (3950_CR56) 2014; 16 E Theresia (3950_CR49) 2020; 21 TM Malta (3950_CR44) 2018; 20 A Mahajan (3950_CR31) 2015; 70 S Xu (3950_CR6) 2020; 476 L Xianwang (3950_CR20) 2021; 31 |
| References_xml | – volume: 39 start-page: 1 issue: 1 year: 2022 ident: 3950_CR36 publication-title: Brain Tumor Pathol doi: 10.1007/s10014-021-00417-y – volume: 21 start-page: 527 issue: 4 year: 2019 ident: 3950_CR11 publication-title: Neuro Oncol doi: 10.1093/neuonc/noz004 – volume: 23 start-page: 1231 issue: 8 year: 2021 ident: 3950_CR5 publication-title: Neuro Oncology doi: 10.1093/neuonc/noab106 – volume: 70 start-page: 1060 issue: 10 year: 2015 ident: 3950_CR31 publication-title: Clin Radiol doi: 10.1016/j.crad.2015.06.082 – volume: 31 start-page: 132 issue: 1 year: 2021 ident: 3950_CR20 publication-title: J Neuroimaging doi: 10.1111/jon.12789 – volume: 296 start-page: 111 issue: 1 year: 2020 ident: 3950_CR30 publication-title: Radiology doi: 10.1148/radiol.2020191832 – volume: 19 start-page: 862 issue: 6 year: 2017 ident: 3950_CR51 publication-title: Neuro Oncol doi: 10.1093/neuonc/now256 – volume: 125 start-page: 531 issue: 3 year: 2015 ident: 3950_CR8 publication-title: J Neuro-oncol doi: 10.1007/s11060-015-1909-8 – volume: 11 start-page: 11 issue: 1 year: 2021 ident: 3950_CR12 publication-title: Sci Rep doi: 10.1038/s41598-021-95958-9 – volume: 86 start-page: 10 year: 2022 ident: 3950_CR29 publication-title: Magn Reson Imaging doi: 10.1016/j.mri.2021.11.001 – volume: 12 start-page: 873839 year: 2022 ident: 3950_CR52 publication-title: Front Oncol doi: 10.3389/fonc.2022.873839 – volume: 7 start-page: 8905 issue: 12 year: 2014 ident: 3950_CR47 publication-title: Int J Clin Exp Pathol – volume: 74 start-page: 1784 issue: 6 year: 1994 ident: 3950_CR23 publication-title: Cancer doi: 10.1002/1097-0142(19940915)74:6<1784::AID-CNCR2820740622>3.0.CO;2-D – volume: 29 start-page: 192 issue: 4 year: 2012 ident: 3950_CR38 publication-title: Brain Tumor Pathol doi: 10.1007/s10014-012-0084-2 – volume: 100 start-page: 1856 issue: 10 year: 2009 ident: 3950_CR53 publication-title: Cancer Sci doi: 10.1111/j.1349-7006.2009.01259.x – volume: 10 start-page: 641 issue: 3 year: 2014 ident: 3950_CR13 publication-title: J Cancer Res Ther doi: 10.4103/0973-1482.139154 – volume: 12 start-page: 143 issue: 3 year: 2006 ident: 3950_CR32 publication-title: Pathol Oncol Res doi: 10.1007/BF02893360 – volume: 161 start-page: 401 issue: 2 year: 1986 ident: 3950_CR57 publication-title: Radiology doi: 10.1148/radiology.161.2.3763909 – volume: 120 start-page: e762 year: 2018 ident: 3950_CR22 publication-title: World Neurosurg doi: 10.1016/j.wneu.2018.08.163 – volume: 14 start-page: 942 issue: 7 year: 2012 ident: 3950_CR27 publication-title: Neuro Oncology doi: 10.1093/neuonc/nos128 – volume: 13 start-page: 12480 issue: 11 year: 2021 ident: 3950_CR14 publication-title: Am J Transl Res – volume: 170 start-page: 211 year: 1989 ident: 3950_CR25 publication-title: Radiology doi: 10.1148/radiology.170.1.2535765 – volume: 91 start-page: 20170930 issue: 1092 year: 2018 ident: 3950_CR33 publication-title: Br J Radiol doi: 10.1259/bjr.20170930 – volume: 21 start-page: 1063 issue: 4 year: 2020 ident: 3950_CR49 publication-title: Asian Pac J Cancer Prev doi: 10.31557/APJCP.2020.21.4.1063 – volume: 21 start-page: 1 issue: 1 year: 2022 ident: 3950_CR21 publication-title: Mol Cancer doi: 10.1186/s12943-022-01513-z – volume: 127 start-page: 175 issue: 2 year: 2018 ident: 3950_CR45 publication-title: Chromosoma doi: 10.1007/s00412-018-0659-8 – volume: 352 start-page: 987 issue: 10 year: 2005 ident: 3950_CR4 publication-title: N Engl J Med doi: 10.1056/NEJMoa043330 – volume: 48 start-page: 300060520914466 issue: 5 year: 2020 ident: 3950_CR28 publication-title: J Int Med Res doi: 10.1177/0300060520914466 – volume: 476 start-page: 1 year: 2020 ident: 3950_CR6 publication-title: Cancer Lett doi: 10.1016/j.canlet.2020.02.002 – volume: 241 start-page: 839 issue: 3 year: 2006 ident: 3950_CR40 publication-title: Radiology doi: 10.1148/radiol.2413051276 – volume: 15 start-page: 783361 year: 2021 ident: 3950_CR19 publication-title: Front Neurosci doi: 10.3389/fnins.2021.783361 – volume: 14 start-page: 1909 issue: 10 year: 2004 ident: 3950_CR26 publication-title: Eur Radiol doi: 10.1007/s00330-004-2381-6 – volume: 499 start-page: 60 year: 2021 ident: 3950_CR1 publication-title: Cancer Lett doi: 10.1016/j.canlet.2020.10.050 – volume: 131 start-page: 803 issue: 6 year: 2016 ident: 3950_CR2 publication-title: Acta Neuropathol doi: 10.1007/s00401-016-1545-1 – volume: 20 start-page: 608 issue: 5 year: 2018 ident: 3950_CR44 publication-title: Neuro Oncology doi: 10.1093/neuonc/nox183 – volume: 26 start-page: 519 issue: 6 year: 2006 ident: 3950_CR50 publication-title: Neuropathology doi: 10.1111/j.1440-1789.2006.00724.x – volume: 11 start-page: 592155 year: 2020 ident: 3950_CR55 publication-title: Front Neurol doi: 10.3389/fneur.2020.592155 – volume: 151 start-page: 120 year: 2016 ident: 3950_CR58 publication-title: Clin Neurol Neurosurg doi: 10.1016/j.clineuro.2016.10.018 – volume: 12 start-page: 862 issue: 8 year: 2010 ident: 3950_CR35 publication-title: Neuro Oncol doi: 10.1093/neuonc/noq009 – volume: 74 start-page: 4638 issue: 22 year: 2014 ident: 3950_CR18 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-13-3534 – volume: 30 start-page: 2142 issue: 4 year: 2020 ident: 3950_CR16 publication-title: Eur Radiol doi: 10.1007/s00330-019-06548-3 – volume: 37 start-page: 630 issue: 5 year: 2020 ident: 3950_CR43 publication-title: Cancer Cell doi: 10.1016/j.ccell.2020.04.001 – volume: 120 start-page: 297 issue: 3 year: 2010 ident: 3950_CR9 publication-title: Acta Neuropathol doi: 10.1007/s00401-010-0725-7 – volume: 31 start-page: 8197 issue: 11 year: 2021 ident: 3950_CR46 publication-title: Eur Radiol doi: 10.1007/s00330-021-07959-x – volume: 261 start-page: 882 issue: 3 year: 2011 ident: 3950_CR42 publication-title: Radiology doi: 10.1148/radiol.11110686 – volume: 16 start-page: 543 issue: 7 year: 2014 ident: 3950_CR56 publication-title: Neoplasia doi: 10.1016/j.neo.2014.06.003 – volume: 30 start-page: 1101 issue: 9 year: 2015 ident: 3950_CR54 publication-title: Histol Histopathol – volume: 69 start-page: 612 issue: 7 year: 2016 ident: 3950_CR15 publication-title: J Clin Pathol doi: 10.1136/jclinpath-2015-203340 – volume: 48 start-page: 643 issue: 3 year: 2018 ident: 3950_CR17 publication-title: J Magn Reson Imaging doi: 10.1002/jmri.25986 – volume: 15 start-page: 5 issue: 1 year: 2019 ident: 3950_CR39 publication-title: Asia Pac J Clin Oncol doi: 10.1111/ajco.12826 – volume: 58 start-page: 121 issue: 2 year: 2016 ident: 3950_CR41 publication-title: Neuroradiology doi: 10.1007/s00234-015-1606-5 – volume: 32 start-page: 3744 issue: 6 year: 2022 ident: 3950_CR48 publication-title: Eur Radiol doi: 10.1007/s00330-021-08522-4 – volume: 48 start-page: 938 issue: 4 year: 2018 ident: 3950_CR24 publication-title: J Magn Reson Imaging doi: 10.1002/jmri.25963 – volume: 22 start-page: 877 issue: 10 year: 2013 ident: 3950_CR37 publication-title: Seizure doi: 10.1016/j.seizure.2013.08.004 – volume: 16 start-page: 896 issue: 7 year: 2014 ident: 3950_CR3 publication-title: Neuro Oncology doi: 10.1093/neuonc/nou087 – volume: 109 start-page: 188 year: 2018 ident: 3950_CR10 publication-title: Eur J Radiol doi: 10.1016/j.ejrad.2018.11.003 – volume: 125 start-page: e1093 year: 2019 ident: 3950_CR34 publication-title: World Neurosurg doi: 10.1016/j.wneu.2019.02.006 – volume: 11 start-page: 575 issue: 3 year: 2021 ident: 3950_CR7 publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-20-1474 |
| SSID | ssj0024549 |
| Score | 2.4072883 |
| Snippet | Ki-67 labeling index (LI) is an important indicator of tumor cell proliferation in glioma, which can only be obtained by postoperative biopsy at present. This... Background and purpose Ki-67 labeling index (LI) is an important indicator of tumor cell proliferation in glioma, which can only be obtained by postoperative... Background and purposeKi-67 labeling index (LI) is an important indicator of tumor cell proliferation in glioma, which can only be obtained by postoperative... Abstract Background and purpose Ki-67 labeling index (LI) is an important indicator of tumor cell proliferation in glioma, which can only be obtained by... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 119 |
| SubjectTerms | Analysis Apparent diffusion coefficient Biopsy Brain cancer Brain Neoplasms - diagnostic imaging Brain Neoplasms - pathology Brain tumors Care and treatment Cell cycle Cell growth Cell proliferation Classification Diagnosis Diffusion coefficient Diffusion Magnetic Resonance Imaging - methods Diffusion-weighted magnetic resonance imaging Edema Glioma Glioma - diagnostic imaging Glioma - pathology Glioma cells Gliomas Humans Ki-67 Antigen Ki-67 labeling index Labeling Magnetic resonance imaging Magnetic Resonance Imaging - methods Medical prognosis Neoplasm Grading Nervous system Patients Peritumoral edema Retrospective Studies Statistical analysis Surgery Testing Tumors |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxQxFA_Sg3gRtX6M1hJB8CChySSTj-MqLa2yHsRCbyGfdaHOlnZL_31fMjPLDoJenMMeJm-GyfvIez_25ReE3vNoPNQNmUTlEhGdo0R7E0mg2RvlKHN1I-3ymzw9F18uuoudo75KT9hADzwo7ggCOUFVrzpFtegi9QlyEvNaRq99Gypah5w3gamJZQ9gz7RFRsujW8hqsCBAfiKUm46S-1kaqmz9f67JO0lp3jC5k4FOnqDHY-mIF8MnP0UPUv8MPVyOf47vo37R41XpBQKhyhqL1z2G-g5f3xSZsq7hwu2dcGl2v8RTLyFefj_DYU7cjKGWxV9XRCoMblL3rONKrAi_-PJqtf7lnqPzk-Mfn0_JeJwCCZ3kG8Id80LmGFkGlACwrw0yK2NE0p7LLHXi3KUseMrBA_ADrMO1ClChmVbrIPkLtNev-_QK4ZRB5zREw0wSUGI5H2InBdO681Qa3yA2adeGkWu8HHlxZSvm0NIOFrFgEVstYu8b9HH7zPXAtPFX6U_FaFvJwpJdb4Dv2NF37L98p0EfisltiWX4vODGLQkwycKKZReKF021LUgezCQhBsN8eHIaO64Bt7ZVcMFyKHiD3m2Hy5Olr61P67sqUxCcYaJBLwcf204JXq4APMPL1cz7ZnOej_Srn5UhvJANCyle_w8lvUGP2ho4LWHsAO1tbu7SWyjENv6wxtxvk6AtOw priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Nb9MwFLdgSIgL4puOgYyExAFZs2PHHydUENMAlQNiUm9W7DhdpZGUttP-_b3nJt0ipPWQQ_0SxXmfv-T5Z0I-yNoFqBsaVpsqMVVWnNngahZ5E5ypuKjyQtrZL316pn7My3n_wm3Tt1UOMTEH6rqL-I78uDDwA-NS8vPqH8Ndo_Drar-Fxn3yAKnL0KrN_AZwKQA_w0IZq483kNsgLECWYly6krOrUTLKnP3_R-ZbqWncNnkrD508IY_7ApJOdxp_Su6l9hl5OOs_kT8n7bSlS-wIAqHMHUu7lkKVR1drlMHoRpHhO1FseV_QoaOQzn5_p3FM30yhoqU_l0wbCsaSV67TTK8IR7q4WHZ_qxfk7OTbn6-nrN9UgcVSyy2TlQhKN3UtGsAKAP6KqBvjnEo2SN1om6SsUqNkamIA-AeIR1oToU5zhbVRy5fkoO3a9JrQ1BTc8Vg74ZKCQqsKsS61EtaWgWsXJkQMT9fHnnEcN7648Bl5WO13GvGgEZ814q8m5NP-nNWOb-NO6S-otL0kcmXnP7r1wveu5yEVJMCFpjTcqrLmIUFVI4LVdbChiHxCPqLKPXo03F6s-oUJMEnkxvJTI_FJFQVIHo0kwRPjeHgwGt9Hgo2_sdsJeb8fxjOxu61N3WWWQRznhJqQVzsb208JLm4AQsPFzcj6RnMej7TL88wTjpTDSqvDu2_rDXlUZJcomBBH5GC7vkxvodDahnfZm64BKEcl0w priority: 102 providerName: ProQuest |
| Title | An initial study on the predictive value using multiple MRI characteristics for Ki-67 labeling index in glioma |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36774480 https://www.proquest.com/docview/2777787043 https://www.proquest.com/docview/2775613914 https://pubmed.ncbi.nlm.nih.gov/PMC9922464 https://doaj.org/article/467e2877570845d0be1811b86db8b2c0 |
| Volume | 21 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxsxEBZ5QMil9J1NUqNCoYeiVrvS6nEoxS4JaYtDMTWYXsRKq3UN7jp1HNL--47kXddLQw_1YQ_WCCzNjOab9egbhF6wUlvADRUpZeEJzwtKlNUlcbSyWhY0LeJF2uGluBjzj5N8soPadkfNBl7fmdqFflLj5fz1zx-_3oHDv40Or8Sba4hZ4O4QfQhlOqfkdhftQ2SSoaPBkKs_3HuQDLUXZ-6cd4gOmABAxANL5FacinT-fx_aW1GrW1G5FaLO76N7DbbE_bUxPEA7vn6IDobNv-ePUN2v8SwUC4FQpJXFixoDAMRXyyATDj4cyL89DtXwU9wWG-Lh6AN2XWZnDGAXf5oRITHYUbzUjiPzIjzxdD5bfC8eo_H52Zf3F6Tpt0BcLtiKsCK1XFRlmVaQRkBemDlRSa25V5aJSijPWOErznzlLGSGkAwxJR1AOJ0p5QR7gvbqRe2PEPZVRjV1pU6154DBCuvKXPBUqdxSoW2C0nZ3jWvIyENPjLmJSYkSZq0cA8oxUTnmNkGvNnOu1lQc_5QeBKVtJAONdvxisZyaxisNRAkPKaPMJVU8L6n1AHhSq0Rplc0cTdDLoHITzA9-niuaOwuwyECbZfqShZ3KMpA87UiCk7rucGs0prVxk0n4wHnJWYKeb4bDzFD4VvvFTZQJKZ5OeYKerm1ss6TWVBMkO9bXWXN3pJ59ixTigY2YC3783zNP0GEWHScjaXqK9lbLG_8M4NnK9tCunMge2h-cXX4e9eJLjl70Q3iOBl9_A7ufOxE |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLfGkIAL4pvCACOBOCBrTuz444BQ-Zhauu6ANqk3EztOqbQlXdup4p_ib-TZTbpFSLsthx7iFyv2-27e-xmhd6zQFuKGkhQy94RnOSXK6oI4Wlotc5rksZF2fCQGJ_zHJJvsoL9tL0woq2xtYjTURe3Cf-T7qYQLhIuzz_NzEk6NCl9X2yM0NmIx8n_WkLItPw2_AX_fp-nB9-OvA9KcKkBcJtiKsDyxXJRFkZQQLEP2kzpRSq25V5aJUijPWO5LznzpLOQ_EPIzJR0EKjpVygkG895Ct8Hx0pDsycllgsch2Wobc5TYX4IvBTMEXpFQpjNK1h3nF88I-N8TXHGF3TLNK37v4AG63wSsuL-RsIdox1eP0J1x80n-Mar6FZ6FCiQgili1uK4wRJV4vgg0wZrigCjucSixn-K2ghGPfw6x68JFY4ig8WhGhMQgnLFTHkc4R_jF09NZfZY_QSc3st1P0W5VV_45wr5Mqaau0In2HAK73LoiEzxRKrNUaNtDSbu7xjUI5-GgjVMTMx0lzIYjBjhiIkfMuoc-bp-Zb_A9rqX-Epi2pQzY3PFGvZiaRtUNuB4PeajMJFU8K6j1EEUlVonCKps62kMfAstNsCDwei5vGiFgkQGLy_QlCzuVpkC516EEzXfd4VZoTGN5luZST3ro7XY4PBmq6SpfX0SakDfqhPfQs42MbZcEk0tI2WFy2ZG-zpq7I9Xsd8QlDxDHXPAX17_WG3R3cDw-NIfDo9FLdC-N6pGSJNlDu6vFhX8FQd7Kvo6ahdGvm1blfzuWYZw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+initial+study+on+the+predictive+value+using+multiple+MRI+characteristics+for+Ki-67+labeling+index+in+glioma&rft.jtitle=Journal+of+translational+medicine&rft.au=Du%2C+Ningfang&rft.au=Shu%2C+Weiquan&rft.au=Li%2C+Kefeng&rft.au=Deng%2C+Yao&rft.date=2023-02-11&rft.pub=BioMed+Central&rft.eissn=1479-5876&rft.volume=21&rft_id=info:doi/10.1186%2Fs12967-023-03950-w&rft_id=info%3Apmid%2F36774480&rft.externalDocID=PMC9922464 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1479-5876&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1479-5876&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1479-5876&client=summon |